0.2724
price down icon6.07%   -0.0176
after-market Dopo l'orario di chiusura: .28 0.0076 +2.79%
loading
Precedente Chiudi:
$0.29
Aprire:
$0.2907
Volume 24 ore:
667.86K
Relative Volume:
0.06
Capitalizzazione di mercato:
$8.38M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-0.3363
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
-24.31%
1M Prestazione:
-3.61%
6M Prestazione:
-71.02%
1 anno Prestazione:
-87.45%
Intervallo 1D:
Value
$0.2602
$0.3096
Intervallo di 1 settimana:
Value
$0.255
$0.37
Portata 52W:
Value
$0.1639
$2.9893

Bioaffinity Technologies Inc Stock (BIAF) Company Profile

Name
Nome
Bioaffinity Technologies Inc
Name
Telefono
210-698-5334
Name
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Name
Dipendente
57
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
BIAF's Discussions on Twitter

Confronta BIAF con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
BIAF
Bioaffinity Technologies Inc
0.2724 8.38M 9.37M -8.45M -7.27M -0.81
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
429.33 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
203.20 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
547.01 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
121.38 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.24 27.64B 15.50B 1.33B 2.16B 7.34

Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie

pulisher
Jun 18, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading 2.1% Higher – What’s Next? - Defense World

Jun 18, 2025
pulisher
Jun 13, 2025

bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

BIAF’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Kalkine : bioAffinity Technologies BIAF Nasdaq Composite - Kalkine Media

Jun 12, 2025
pulisher
Jun 12, 2025

bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Large Growth in Short Interest - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board - BioSpace

Jun 12, 2025
pulisher
Jun 11, 2025

bioAffinity CEO Joins American Lung Association Texas Leadership Board | BIAFW Stock News - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Gordon Downie Named Chief Medical Officer at bioAffinity Technologies - Medical Product Outsourcing

Jun 10, 2025
pulisher
Jun 05, 2025

BIAFbioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - Revista ADVFN

Jun 05, 2025
pulisher
Jun 04, 2025

Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - mx.advfn.com

Jun 04, 2025
pulisher
Jun 03, 2025

bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAF) Grows By 58.8% - Defense World

Jun 03, 2025
pulisher
May 30, 2025

bioAffinity Receives Nasdaq Non-Compliance Notice - TipRanks

May 30, 2025
pulisher
May 29, 2025

BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors - Insider Monkey

May 29, 2025
pulisher
May 28, 2025

BioAffinity Technologies Announces New U.S. Patent For Novel Broad Spectrum Cancer Therapeutics - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BIAF Gains New Patent for Innovative Cancer Treatment Method | B - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Revolutionary Cancer Treatment Patent: bioAffinity's New Therapy Kills Cancer Cells While Sparing Healthy Ones - Stock Titan

May 28, 2025
pulisher
May 27, 2025

bioAffinity Technologies Enters Sales Agreement with WallachBeth - TipRanks

May 27, 2025
pulisher
May 22, 2025

bioAffinity Technologies (NASDAQ:BIAF) Trading Down 3.1% – What’s Next? - Defense World

May 22, 2025
pulisher
May 22, 2025

BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline - MSN

May 22, 2025
pulisher
May 20, 2025

bioAffinity Technologies names new chief medical officer By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 20, 2025

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer - citybiz

May 20, 2025
pulisher
May 20, 2025

BioAffinity Technologies (BIAF) Appoints Gordon Downie as Chief Medical Officer | BIAF Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

bioAffinity Technologies names new chief medical officer - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

From Olympic Bronze to Cancer Breakthrough: bioAffinity Names Elite Physician as New CMO - Stock Titan

May 20, 2025
pulisher
May 20, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

May 20, 2025
pulisher
May 19, 2025

bioAffinity Technologies Sets 2025 Annual Meeting Date - TipRanks

May 19, 2025
pulisher
May 19, 2025

Earnings roundup: ‘Uncertain’ conditions weigh on companies’ bottom lines - San Antonio Express-News

May 19, 2025
pulisher
May 18, 2025

bioAffinity Technologies Reports Strong Q1 2025 Growth - MSN

May 18, 2025
pulisher
May 15, 2025

bioAffinity Technologies, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

bioAffinity Technologies Reports First Quarter 2025 Results - Business Wire

May 15, 2025
pulisher
May 08, 2025

bioAffinity Technologies Completes $3.2M Public Offering - TipRanks

May 08, 2025
pulisher
May 08, 2025

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering - The Malaysian Reserve

May 08, 2025
pulisher
May 08, 2025

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer - Stock Titan

May 08, 2025
pulisher
May 08, 2025

bioAffinity announces $3.25 million securities offering By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

bioAffinity Technologies completes $3.25 million offering By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

BioAffinity Technologies Closes $3.25 Million Offering - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

bioAffinity Technologies (BIAF) Completes $3.25M Securities Offering | BIAF Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

bioAffinity Technologies completes $3.25 million offering - Investing.com

May 07, 2025
pulisher
May 07, 2025

bioAffinity Technologies Announces Closing of $3.25 Million Offering - Bluefield Daily Telegraph

May 07, 2025
pulisher
May 07, 2025

bioAffinity Technologies Boosts Data Acquisition for CyPath Lung Test - Medical Product Outsourcing

May 07, 2025
pulisher
May 07, 2025

BioAffinity Technologies announces pricing of $3.25M offering - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Crude Oil Rises Sharply; US Trade Deficit Widens In March - Benzinga

May 06, 2025
pulisher
May 06, 2025

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering - Eastern Progress

May 06, 2025
pulisher
May 06, 2025

The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies - NewsBreak: Local News & Alerts

May 06, 2025
pulisher
May 06, 2025

Cancer Detection Biotech bioAffinity Secures Fresh $3.25M Funding: Key Details of Latest Stock Offering - Stock Titan

May 06, 2025
pulisher
May 06, 2025

bioAffinity announces $3.25 million securities offering - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

Dow Falls Over 250 Points; Marriott Posts Upbeat Earnings - Benzinga

May 06, 2025

Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$176.92
price up icon 0.18%
diagnostics_research WAT
$350.22
price down icon 0.48%
diagnostics_research LH
$261.89
price up icon 0.73%
$161.76
price up icon 0.12%
diagnostics_research MTD
$1,209.08
price up icon 0.28%
diagnostics_research IQV
$164.24
price down icon 0.25%
Capitalizzazione:     |  Volume (24 ore):